Utah Medical Products (UTMD) Return on Capital Employed (2011 - 2026)

Utah Medical Products' Return on Capital Employed history runs 16 years deep, the most recent figure standing at 1.57% for Q1 2026.

• In Q1 2026, Return on Capital Employed fell 931.0% year-over-year to 1.57%; the TTM figure through Mar 2026 stood at 1.57% (down 931.0% YoY), while the FY2025 annual figure was 2.07%, down 17.0% from the prior year.
• Return on Capital Employed was 1.57% for Q1 2026 at Utah Medical Products, down from 2.07% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 17.88% in Q3 2022 to a low of 0.14% in Q3 2024.
• Historically, Return on Capital Employed has averaged 6.44% across 5 years, with a median of 2.12% in 2023.
• The sharpest annual moves came in 2023 and 2025: Return on Capital Employed slumped 1730 bps in 2023, then soared 995 bps in 2025.
• A 5-year view of Return on Capital Employed shows it stood at 2.27% in 2022, then slipped by 20 bps to 1.82% in 2023, then surged by 509 bps to 11.11% in 2024, then plunged by 81 bps to 2.07% in 2025, then decreased by 24 bps to 1.57% in 2026.
• The last three Return on Capital Employed figures came in at 1.57% (Q1 2026), 2.07% (Q4 2025), and 10.04% (Q3 2025), per Business Quant data.